問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberA0081245

2011-06-01 - 2013-12-31

Phase III

Terminated4

ICD-10M60.80

Other myositis, unspecified site

ICD-10M60.811

Other myositis, right shoulder

ICD-10M60.812

Other myositis, left shoulder

ICD-10M60.819

Other myositis, unspecified shoulder

ICD-10M60.821

Other myositis, right upper arm

ICD-10M60.822

Other myositis, left upper arm

ICD-10M60.829

Other myositis, unspecified upper arm

ICD-10M60.831

Other myositis, right forearm

ICD-10M60.832

Other myositis, left forearm

ICD-10M60.839

Other myositis, unspecified forearm

ICD-10M60.841

Other myositis, right hand

ICD-10M60.842

Other myositis, left hand

ICD-10M60.849

Other myositis, unspecified hand

ICD-10M60.851

Other myositis, right thigh

ICD-10M60.852

Other myositis, left thigh

ICD-10M60.859

Other myositis, unspecified thigh

ICD-10M60.861

Other myositis, right lower leg

ICD-10M60.862

Other myositis, left lower leg

ICD-10M60.869

Other myositis, unspecified lower leg

ICD-10M60.871

Other myositis, right ankle and foot

ICD-10M60.872

Other myositis, left ankle and foot

ICD-10M60.879

Other myositis, unspecified ankle and foot

ICD-10M60.88

Other myositis, other site

ICD-10M60.89

Other myositis, multiple sites

ICD-10M60.9

Myositis, unspecified

ICD-10M79.1

Myalgia

ICD-10M79.7

Fibromyalgia

ICD-9729.1

Myalgia and myositis, unspecified

  • Sponsor

  • Trial scale

    Multi-Regional Multi-Center

  • Update

    2025/08/20

Investigators and Locations

Principal Investigator 楊智超 Division of Neurology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Completed

Principal Investigator Long-Sun Ro Division of Neurology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Completed

Principal Investigator 巫錫霖 Division of Neurology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Completed

Principal Investigator Chung-Hsiang Liu Division of Neurology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Completed

Condition/Disease

Objectives

Test Drug

Active Ingredient

Dosage Form

Dosage

Endpoints

Inclution Criteria

The Estimated Number of Participants

  • Taiwan

    25 participants

  • Global

    290 participants